drugset / Trial / NCT00003617

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

NCT00003617

Phase 3 Unknown 200 enrolled Lymphoma Trials Office
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known whether chlorambucil is more effective than observation in treating low-grade lymphoma of the stomach. PURPOSE: Randomized phase III trial to compare the effectiveness of chlorambucil with that of no further therapy following anti-Helicobacter therapy in treating patients with low-grade lymphoma of the stomach.

Timeline

Start
1995-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorambucil Other / unclassified Oral
Subject Clarithromycin Small molecule
Subject Omeprazole Other / unclassified
Subject tinidazole Small molecule

Indications